Skip to main content
Premium Trial:

Request an Annual Quote

Balance of Males and Females

The number of male cells, tissues, and animals used in biomedical research outstrip the number of female ones used — by some 5.5 to 1 in neuroscience, notes Bethany Brookshire at Scicurious.

The US National Institutes of Health announced a policy change last May to try to fix that imbalance. The agency is beginning by requiring grantees to report the sex of the cells, tissues, and animals used in their studies.

As Brookshire reports, some researchers are happy with the new requirements while others say it is not funded well enough to work.

By focusing primarily on male cells, tissues, and animals, researchers maybe missing effects specific to females. For instance, dosage for the sleeping pill Ambien (zolpidem) for women had to be halved after it was discovered that they metabolized the drug more slowly and should take a smaller dose than men — an effect that might have been caught earlier had there been a balance of males and females in the clinical studies, Brookshire adds.

"Including females will require many labs to think more broadly about their approach, so as to include females in a cost-effective way," Jill Becker, a behavioral neuroscientist at the University of Michigan tells her. "These changes will be good for science in the long run."

However, others are worried about the added variables and added cost that will arise when folding another sex into an experimental design. The National Institute of Child Health and Development's Douglas Fields tells Brookshire that "the current approach hasn't given enough thought to the realities and practicalities" of such projects.

"I share the goals of the current approach, but my concern is that it will fail and cause a backlash among the public and undermine the effort," he adds.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.